NicErase-SL sublingual lobeline sulfate: Began Phase IIb trial

DynaGen Inc. (DYGN), Cambridge, Mass. Product: NicErase-SL sublingual lobeline sulfate Indication: Smoking cessation Status: Began Phase IIb trial of three different doses in 160 smokers to test effic...